88 related articles for article (PubMed ID: 21397911)
21. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia.
Brand PL; van Lingen RA; Brus F; Talsma MD; Elzenga NJ
Acta Paediatr; 1993; 82(6-7):614-7. PubMed ID: 8339005
[TBL] [Abstract][Full Text] [Related]
22. Neonatal glucocorticosteroid treatment causes systolic dysfunction and compensatory dilation in early life: studies in 4-week-old prepubertal rats.
Bal MP; de Vries WB; van der Leij FR; van Oosterhout MF; Berger RM; Baan J; van der Wall EE; van Bel F; Steendijk P
Pediatr Res; 2005 Jul; 58(1):46-52. PubMed ID: 15985685
[TBL] [Abstract][Full Text] [Related]
23. Evidence-based neonatal pharmacotherapy: postnatal corticosteroids.
Watterberg K
Clin Perinatol; 2012 Mar; 39(1):47-59. PubMed ID: 22341536
[TBL] [Abstract][Full Text] [Related]
24. [Secondary myocardial hypertrophy in a very small premature infant treated with dexamethasone].
Korsch E; Gillor A; Groneck P; Bläker F
Monatsschr Kinderheilkd; 1993 Feb; 141(2):112-5. PubMed ID: 8459811
[TBL] [Abstract][Full Text] [Related]
25. Retrospective Analysis of Short-Term Respiratory Outcomes of Three Different Steroids Used in Clinical Practice in Intubated Preterm Infants.
Nath S; Reynolds AM; Lakshminrusimha S; Ma C; Hudak ML; Ryan RM
Am J Perinatol; 2020 Dec; 37(14):1425-1431. PubMed ID: 31382299
[TBL] [Abstract][Full Text] [Related]
26. [Glucocorticoid-induced hypertrophic cardiomyopathy in premature infants: apropos of 4 cases].
Boeuf B; Maragnes P; Belzic I; Lacotte J; Bonte JB; Guillois B
Arch Pediatr; 1997 Feb; 4(2):152-7. PubMed ID: 9097827
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of left ventricular function in preterm infants with bronchopulmonary dysplasia using various echocardiographic techniques.
Bokiniec R; Własienko P; Borszewska-Kornacka M; Szymkiewicz-Dangel J
Echocardiography; 2017 Apr; 34(4):567-576. PubMed ID: 28370301
[TBL] [Abstract][Full Text] [Related]
28. The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood.
Kipps A; Alexander M; Colan SD; Gauvreau K; Smoot L; Crawford L; Darras BT; Blume ED
Pediatr Cardiol; 2009 Apr; 30(3):306-10. PubMed ID: 18716706
[TBL] [Abstract][Full Text] [Related]
29. Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia.
Marinelli KA; Burke GS; Herson VC
J Pediatr; 1997 Apr; 130(4):594-602. PubMed ID: 9108858
[TBL] [Abstract][Full Text] [Related]
30. Noncircumferential myofiber function: impact on early diastolic filling in children.
Michelfelder EC; Khoury P; Witt SA; Glascock BJ; Kimball TR
J Am Soc Echocardiogr; 2001 Nov; 14(11):1065-9. PubMed ID: 11696829
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive drugs and hypertrophic cardiomyopathy.
Brand PL; Brus F
Lancet; 1995 Jun; 345(8965):1644. PubMed ID: 7540240
[No Abstract] [Full Text] [Related]
32. Effect of dexamethasone exposure on the neonatal unit on the school age lung function of children born very prematurely.
Harris C; Crichton S; Zivanovic S; Lunt A; Calvert S; Marlow N; Peacock JL; Greenough A
PLoS One; 2018; 13(7):e0200243. PubMed ID: 29985964
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular consequences of bronchopulmonary dysplasia in prematurely born preschool children.
Koroglu OA; Yalaz M; Levent E; Akisu M; Kültürsay N
Neonatology; 2013; 104(4):283-9. PubMed ID: 24107436
[TBL] [Abstract][Full Text] [Related]
34. Invasive Hemodynamics of Myocardial Disease: Systolic and Diastolic Dysfunction (and Hypertrophic Obstructive Cardiomyopathy).
Eskander M; Kern MJ
Interv Cardiol Clin; 2017 Jul; 6(3):297-307. PubMed ID: 28600085
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of dexamethasone in premature neonates.
Lugo RA; Nahata MC; Menke JA; McClead RE
Eur J Clin Pharmacol; 1996; 49(6):477-83. PubMed ID: 8706773
[TBL] [Abstract][Full Text] [Related]
36. Hypertrophic intraventricular flow obstruction after very-low-dose dexamethasone (Minidex) in preterm infants: case presentation and review of the literature.
Paech C; Wolf N; Thome UH; Knüpfer M
J Perinatol; 2014 Mar; 34(3):244-6. PubMed ID: 24573211
[TBL] [Abstract][Full Text] [Related]
37. Dexamethasone for pulmonary interstitial emphysema in preterm infants.
Fitzgerald D; Willis D; Usher R; Outerbridge E; Davis GM
Biol Neonate; 1998; 73(1):34-9. PubMed ID: 9458940
[TBL] [Abstract][Full Text] [Related]
38. Hypertrophic Cardiomyopathy After a Single Dose of Dexamethasone in a Preterm Infant.
Kale Y; Aydemir O; Ceylan O; Bas AY; Demirel N
Pediatr Neonatol; 2015 Aug; 56(4):268-70. PubMed ID: 23639746
[TBL] [Abstract][Full Text] [Related]
39. ACE inhibition for severe bronchopulmonary dysplasia - an approach based on physiology.
Sehgal A; Krishnamurthy MB; Clark M; Menahem S
Physiol Rep; 2018 Sep; 6(17):e13821. PubMed ID: 30187692
[TBL] [Abstract][Full Text] [Related]
40. [Early cardiovascular effects of corticotherapy for bronchopulmonary dysplasia].
Lenclen R; Karam T; Gajdos V; Mourdie J; Hoenn E; Campot K; Paupe A
Arch Pediatr; 2001 Jan; 8(1):32-8. PubMed ID: 11218581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
